FDAnews
www.fdanews.com/articles/85175-biosystems-international-licences-northeastern-university-technology-for-biomarker-discovery

BIOSYSTEMS INTERNATIONAL LICENCES NORTHEASTERN UNIVERSITY TECHNOLOGY FOR BIOMARKER DISCOVERY

March 10, 2006

BioSystems International and Northeastern University (Boston MA) announce that they have signed a Licence Agreement for The University's "Monoclonal antibody based biomarker discovery and development platform." BioSystems International (BSI) discovers and validates biomarkers through partnerships with pharmaceutical, biotechnology and diagnostics companies and in-house research programs or academic collaborations.
International News Service